Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For WSM
Valuation Weak
28%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 7.42 1.55 1.45
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -6.44 0.23 0.24
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.74 34.41 33.17
Cash -0.67 19.54 19.67
Capex 26.39 -0.62 -0.84
Free Cash Flow -69.88 2.92 9.69
Revenue -27.22 25.86 35.53
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 5.04 0.48 0.46
Operating Margin -3.29 0.20 0.20
ROA -23.40 0.05 0.07
ROE -27.82 0.12 0.17
ROIC -27.45 0.07 0.10
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of WSM is permitted for members.
5 Growth
The "Growth Entry" for the Focus of WSM is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of WSM is permitted for members.